Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Priveq Investment in connection with the investment in ROL
Mandate

Vinge has advised Priveq Investment in connection with the investment in ROL

June 16, 2021 Employment and Benefits Banking and Finance Real Estate and Construction Intellectual Property IT, Telecommunications and Outsourcing M&A Environmental Law

Today ROL offers workspace solutions including software and ergonomically optimized office furniture and store concept solutions. ROL’s offering is sold globally both through ROL’s own sales organization and distributors. In 2020, ROL had a turnover of approximately SEK 1.6 billion and 890 employees in ten different countries.

The Hjelm family has partnered with Priveq Investment as a new minority owner to support the company in its accelerated growth strategy. The Hjelm family will continue as majority owners in ROL, with Arne Karlsson continuing as the Chairman of the Board.

Vinge’s team consisted of Jonas Johansson, Karl Klackenberg and Jesper Lindvall (M&A), together with Kristoffer Larson (Real Estate), Johan Cederblad and Lina Österberg (Environment), Jolene Reimerson and Mathilda Persson (IT, Agreements and GDPR), Sofia Bergenstråhle (IP), Karl-Gustaw Tobola (Financing), Ebba Svenburg (Employment), Carl Bruneheim and Viktoria Owetz Leyva (VDR).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025